Suchergebnisse - "HEMATOLOGIC malignancies"

The mediating role of illness perception in the relationship between social support and treatment burden: a cross-sectional study among patients with hematologic neoplasms.

Autoren: Wang, Yuanyuan Xue, Mengxin Yuan, Min et al.

Quelle: Current Psychology. Oct2025, Vol. 44 Issue 19, p15911-15919. 9p.

Schlagwörter: *SOCIAL support, *MEDICAL personnel, *PATIENT surveys, HEMATOLOGIC malignancies, CROSS-sectional method, PSYCHOLOGY of the sick

Use of a Foamy‐Virus Vector System to Produce an 'Off‐the‐Shelf' Fcγ‐CR‐T Cell Product for the Treatment of Haematological and Solid Tumour Malignancies.

Autoren: Lazana, Ioanna Simantirakis, Emmanouil Kourous, Evangelos et al.

Quelle: Immunology. Dec2025, Vol. 176 Issue 4, p520-529. 10p.

Schlagwörter: *HEMATOLOGIC malignancies, *TUMORS, *IMMUNOTHERAPY, *FOAMY viruses, *MONOCLONAL antibodies, *GENE therapy, *ANTIBODY-dependent cell cytotoxicity, *CYTOTOXIC T cells

Next-generation immune profiling – beyond blood cancer cells.

Autoren: Unger, Susanne Nuñez, Nicolás Becher, Burkhard et al.

Quelle: Trends in Molecular Medicine. Dec2025, Vol. 31 Issue 12, p1140-1153. 14p.

Schlagwörter: *HEMATOLOGIC malignancies, *DIAGNOSIS, *INDIVIDUALIZED medicine, *TUMOR-infiltrating immune cells, *IMMUNE recognition, *RNA sequencing, *TREATMENT effectiveness, *GENE expression profiling

Assessment of drug-drug interactions among patients with hematologic malignancy: A clinical pharmacist-led study.

Autoren: Zarrabi, Sogol Hosseini, Elham Sadeghi, Kourosh et al.

Quelle: Journal of Oncology Pharmacy Practice. Dec2025, Vol. 31 Issue 8, p1256-1263. 8p.

Schlagwörter: *RISK assessment, *HEMATOLOGIC malignancies, *DRUG side effects, *PATIENT safety, *DATA analysis, *HOSPITAL care, *INTERVIEWING, *CANCER patients, *SEVERITY of illness index, *DESCRIPTIVE statistics, *LONGITUDINAL method, *DRUG interactions, *RESEARCH methodology, *STATISTICS, *DATA analysis software

Geografische Kategorien: IRAN

Relationship between spleen volume and diameter for assessment of response to treatment on CT in patients with hematologic malignancies enrolled in clinical trials.

Autoren: Hasenstab, Kyle A. Lu, Jie Leong, Lambert T. et al.

Quelle: Abdominal Radiology. Dec2025, Vol. 50 Issue 12, p5799-5809. 11p.

Schlagwörter: *HEMATOLOGIC malignancies, *TREATMENT effectiveness, *PREDICTION models, *CLINICAL trials, *COMPUTED tomography

Geografische Kategorien: LUGANO (Switzerland)

Burden of haematological malignancies among children, adolescents and young adults: Global and high‐income region insights from the GBD 2021 study.

Autoren: Xu, Shujuan Yang, Baihua Liu, Xinxin et al.

Quelle: British Journal of Haematology. Nov2025, p1. 11p. 5 Illustrations.

Schlagwörter: *HEMATOLOGIC malignancies, *LEUKEMIA, *DISEASE incidence, *GLOBAL burden of disease, *MORTALITY, *YOUNG adults, *SCHOOL children, *TEENAGERS

Incidence and risk factors of hypothyroidism in patients with hematological malignancies compared to healthy population: a systematic review and meta-analysis.

Autoren: Moradi, Zahra Toutounchian, Samaneh Eghbali, Zahra et al.

Quelle: BMC Cancer. 11/19/2025, Vol. 25 Issue 1, p1-15. 15p.

Schlagwörter: *HYPOTHYROIDISM, *HEMATOLOGIC malignancies, *RADIOTHERAPY, *CANCER chemotherapy, *DISEASE incidence, *DISEASE risk factors

When cure ends: lived experiences of palliative care among Jordanian adults with hematological malignancies.

Autoren: Alnaeem, Mohammad M. Bawadi, Hala Abu Sharour, Loai

Quelle: Psychology, Health & Medicine. Nov2025, p1-21. 21p.

Schlagwörter: *TERMINAL care, *HEMATOLOGIC malignancies, *SOCIAL support, *PALLIATIVE treatment, *SPIRITUALITY, *QUALITATIVE research, *PATIENTS' attitudes

Clinical outcomes and safety of CD47-targeted immunotherapies across hematologic malignancies: a systematic review of monoclonal antibodies and fusion proteins in combination strategies.

Autoren: Mirza, Wajahat Dadan, Sundas Ahmad, Eshan et al.

Quelle: Clinical & Experimental Medicine. 11/11/2025, Vol. 25 Issue 1, p1-14. 14p.

Schlagwörter: *HEMATOLOGIC malignancies, *IMMUNOTHERAPY, *TREATMENT effectiveness, *COMBINATION drug therapy, *SAFETY, *MONOCLONAL antibodies, *CHIMERIC proteins, *CD47 antigen

The emerging role of cancer-associated fibroblasts in hematological malignancies: from their influence on tumor progression and drug resistance to novel therapeutic opportunities.

Autoren: Jalilivand, Sahar Yazdanparast, Somayeh Bakhtiyaridovvombaygi, Mehdi et al.

Quelle: Clinical & Experimental Medicine. 11/11/2025, Vol. 25 Issue 1, p1-19. 19p.

Schlagwörter: *HEMATOLOGIC malignancies, *DRUG resistance, *DRUG resistance in cancer cells, *FIBROBLASTS, *CANCER invasiveness, *TUMOR microenvironment, *EXTRACELLULAR matrix, *THERAPEUTICS

Enhancement of CAR-T cell efficacy and persistence via CD30 costimulation and NF-κB signaling.

Autoren: Su, Yang Yang, Guang Chen, Bi et al.

Quelle: Molecular Cancer. 11/13/2025, Vol. 24 Issue 1, p1-17. 17p.

Schlagwörter: *NF-kappa B, *HEMATOLOGIC malignancies, *CYTOKINES, *CHIMERIC antigen receptors, *TUMORS, *ANIMAL models in research

How Early Is Too Early? Use of Lineage‐Specific Chimerism in Early Detection of Donor‐Derived Malignancy After Allogeneic Stem Cell Transplant: A Case Report.

Autoren: Zaman-Pope, Victor Fulford, Adrienne Deotare, Uday et al.

Quelle: Case Reports in Hematology. 11/11/2025, Vol. 2025, p1-4. 4p.

Schlagwörter: *CHIMERISM, *HEMATOLOGIC malignancies, *GRAFT versus host disease, *EARLY diagnosis, *PANCYTOPENIA, *MYELODYSPLASTIC syndromes, *GRAFT versus host reaction, *STEM cell donors

Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.

Autoren: Hahn, Theresa Herr, Megan M. Wallace, Paul K. et al.

Quelle: Leukemia & Lymphoma. Nov2025, p1-5. 5p. 2 Illustrations.

Schlagwörter: *HEMATOLOGIC malignancies, *T cells, *TREATMENT effectiveness, *EPIDEMIOLOGY, *KILLER cells, *DENDRITIC cells, *B cells

Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis.

Autoren: Lin, Pao-Yen Zeng, Bing-Yan Hsu, Chih-Wei et al.

Quelle: Biomolecules (2218-273X). Nov2025, Vol. 15 Issue 11, p1622. 16p.

Schlagwörter: *HEMATOLOGIC malignancies, *GLUCAGON-like peptide-1 agonists, *LYMPHOMAS, *MEDICAL care research, *SODIUM-glucose cotransporter 2 inhibitors, *LEUKEMIA

A Brief Review on the Role of the Transcription Factor PBX1 in Hematologic Malignancies.

Autoren: Chatzileontiadou, Sofia Boulogeorgou, Kassiani Frouzaki, Christina et al.

Quelle: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 21, p10545. 11p.

Schlagwörter: *HEMATOLOGIC malignancies, *LEUKEMIA, *GENE expression, *BIOMARKERS, *TRANSCRIPTION factors, *NEOPLASTIC cell transformation, *DRUG target

Role of Palliative Care in Onco-Hematology Retrospective Observational Cohort Study in Deceased In-Hospital Patients with SACT at the End of Life: Experience with Real-World Data from a Cancer Monographic Institution.

Autoren: Pétriz, Lourdes Asensio, Esther Loureiro, Eva et al.

Quelle: Cancers. Nov2025, Vol. 17 Issue 21, p3467. 20p.

Schlagwörter: *PSYCHOLOGY of the terminally ill, *HEMATOLOGIC malignancies, *PALLIATIVE treatment, *T-test (Statistics), *RESEARCH funding, *SCIENTIFIC observation, *KRUSKAL-Wallis Test, *FISHER exact test, *HOSPITAL mortality, *RETROSPECTIVE studies, *DESCRIPTIVE statistics, *CANCER chemotherapy, *LONGITUDINAL method, *LEUKEMIA, *KAPLAN-Meier estimator, *MEDICAL records, *ACQUISITION of data, *LUNG tumors, *ANALYSIS of variance, *CANCER patient psychology, *SOCIAL support, *DATA analysis software, *TUMOR classification, *MEDICAL referrals, *DISEASE progression

Geografische Kategorien: CATALONIA (Spain)

Concentration–QTc Analysis of Valemetostat in Patients With Hematologic Malignancies.

Autoren: Tachibana, Masaya Poland, Bill Kakurai, Yasuyuki et al.

Quelle: CTS: Clinical & Translational Science. Nov2025, Vol. 18 Issue 11, p1-9. 9p.

Schlagwörter: *HEMATOLOGIC malignancies, *ELECTROCARDIOGRAPHY, *RANDOM effects model, *ANTINEOPLASTIC agents, *ACUTE myeloid leukemia, *LONG QT syndrome, *LYMPHOMAS, *B cell lymphoma

Integrating Nature Into Oncology: Enhancing Hematological Malignancies Therapies With Natural Medicine.

Autoren: Tian, Yaoyao Ni, Baoyi Cai, Dandan et al.

Quelle: Cancer Medicine. Nov2025, Vol. 14 Issue 21, p1-20. 20p.

Schlagwörter: *HEMATOLOGIC malignancies, *DRUG resistance, *HERBAL medicine, *ALTERNATIVE medicine, *MEDICAL practice, *CANCER treatment, *APOPTOSIS, *CHEMOSENSITIZERS

Construction and validation of a frailty risk prediction model for geriatric hematologic neoplasms patients: A cross-sectional study.

Autoren: Zhao, Jinying Liu, Yating Kan, Zhongfan et al.

Quelle: Technology & Health Care. Nov2025, Vol. 33 Issue 6, p2581-2597. 17p.

Schlagwörter: *FRAILTY, *HEMATOLOGIC malignancies, *RISK assessment, *LOGISTIC regression analysis, *HEALTH outcome assessment, *GERIATRICIANS, *MODEL validation

Reporting and enrollment disparities in hematologic malignancy trials between 2000–2023.

Autoren: Gong, Inna Y. Rafinejad-Farahani, Bahar Majeed, Haris et al.

Quelle: Leukemia & Lymphoma. Nov2025, p1-14. 14p. 4 Illustrations.

Schlagwörter: *HEMATOLOGIC malignancies, *CLINICAL trials, *RESEARCH funding, *DIVERSITY in the workplace, *DEMOGRAPHIC databases, *SOCIAL marginality, *PATIENT selection

Geografische Kategorien: UNITED States

Firma/Körperschaft: NATIONAL Institutes of Health (U.S.)